Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 167

1.

Drug delivery nanoparticles in treating chemoresistant tumor cells.

Barrera G, Daga M, Ferrara B, Dianzani C, Pizzimenti S, Argenziano M, Cavalli R, Trotta F.

Curr Med Chem. 2016 Dec 5. [Epub ahead of print]

PMID:
27919217
2.

Hybrid Coronary Revascularization for the Treatment of Multivessel Coronary Artery Disease: A Multicenter Observational Study.

Puskas JD, Halkos ME, DeRose JJ, Bagiella E, Miller MA, Overbey J, Bonatti J, Srinivas VS, Vesely M, Sutter F, Lynch J, Kirkwood K, Shapiro TA, Boudoulas KD, Crestanello J, Gehrig T, Smith P, Ragosta M, Hoff SJ, Zhao D, Gelijns AC, Szeto WY, Weisz G, Argenziano M, Vassiliades T, Liberman H, Matthai W, Ascheim DD.

J Am Coll Cardiol. 2016 Jul 26;68(4):356-65. doi: 10.1016/j.jacc.2016.05.032.

PMID:
27443431
3.

Arrhythmogenic effect of androgens on the rat heart.

Argenziano M, Tiscornia G, Moretta R, Casal L, Potilinski C, Amorena C, Gras EG.

J Physiol Sci. 2017 Jan;67(1):217-225.

PMID:
27241707
4.

GSH-targeted nanosponges increase doxorubicin-induced toxicity "in vitro" and "in vivo" in cancer cells with high antioxidant defenses.

Daga M, Ullio C, Argenziano M, Dianzani C, Cavalli R, Trotta F, Ferretti C, Zara GP, Gigliotti CL, Ciamporcero ES, Pettazzoni P, Corti D, Pizzimenti S, Barrera G.

Free Radic Biol Med. 2016 Aug;97:24-37. doi: 10.1016/j.freeradbiomed.2016.05.009.

PMID:
27184956
5.

Minimally Invasive Cardiovascular Surgery: Incisions and Approaches.

Langer NB, Argenziano M.

Methodist Debakey Cardiovasc J. 2016 Jan-Mar;12(1):4-9. doi: 10.14797/mdcj-12-1-4.

6.

Vascular Operations Performed by Cardiothoracic Surgeons: The Society of Thoracic Surgeons Survey.

Ikonomidis JS, Ad N, Aldea GS, Argenziano M, Galloway AC, Hagberg RC, Kormos RL, Lawton JS, Mihaljevic T, Reece TB, Tseng EE.

Ann Thorac Surg. 2016 Aug;102(2):589-92. doi: 10.1016/j.athoracsur.2016.01.076.

PMID:
27083242
7.

Bridging Anticoagulation After Mechanical Aortic Heart Valve Replacement: A Questionable Routine.

Guglielmetti LC, Sorabella R, Chiuzan C, Najjar M, Castillero E, Lambert D, Kim MJ, Kurlansky P, Borger MA, Argenziano M, Smith CR, George I.

Ann Thorac Surg. 2016 Jul;102(1):48-54. doi: 10.1016/j.athoracsur.2016.01.030.

PMID:
27068176
8.

Rate Control versus Rhythm Control for Atrial Fibrillation after Cardiac Surgery.

Gillinov AM, Bagiella E, Moskowitz AJ, Raiten JM, Groh MA, Bowdish ME, Ailawadi G, Kirkwood KA, Perrault LP, Parides MK, Smith RL 2nd, Kern JA, Dussault G, Hackmann AE, Jeffries NO, Miller MA, Taddei-Peters WC, Rose EA, Weisel RD, Williams DL, Mangusan RF, Argenziano M, Moquete EG, O'Sullivan KL, Pellerin M, Shah KJ, Gammie JS, Mayer ML, Voisine P, Gelijns AC, O'Gara PT, Mack MJ; CTSN..

N Engl J Med. 2016 May 19;374(20):1911-21. doi: 10.1056/NEJMoa1602002.

9.

Two-Year Outcomes of Surgical Treatment of Moderate Ischemic Mitral Regurgitation.

Michler RE, Smith PK, Parides MK, Ailawadi G, Thourani V, Moskowitz AJ, Acker MA, Hung JW, Chang HL, Perrault LP, Gillinov AM, Argenziano M, Bagiella E, Overbey JR, Moquete EG, Gupta LN, Miller MA, Taddei-Peters WC, Jeffries N, Weisel RD, Rose EA, Gammie JS, DeRose JJ Jr, Puskas JD, Dagenais F, Burks SG, El-Hamamsy I, Milano CA, Atluri P, Voisine P, O'Gara PT, Gelijns AC; CTSN..

N Engl J Med. 2016 May 19;374(20):1932-41. doi: 10.1056/NEJMoa1602003.

10.

Doxorubicin-Loaded Nanobubbles Combined with Extracorporeal Shock Waves: Basis for a New Drug Delivery Tool in Anaplastic Thyroid Cancer.

Marano F, Argenziano M, Frairia R, Adamini A, Bosco O, Rinella L, Fortunati N, Cavalli R, Catalano MG.

Thyroid. 2016 May;26(5):705-16. doi: 10.1089/thy.2015.0342.

PMID:
26906083
11.

Nanobubbles: a promising efficient tool for therapeutic delivery.

Cavalli R, Soster M, Argenziano M.

Ther Deliv. 2016;7(2):117-38. doi: 10.4155/tde.15.92. Review.

PMID:
26769397
12.

Residual Tricuspid Regurgitation following Tricuspid Valve Repair during Concomitant Valve Surgery Worsens Late Survival.

Sorabella RA, Mamuyac E, Yerebakan H, Najjar M, Choi V, Takayama H, Naka Y, Argenziano M, Smith CR, George I.

Heart Surg Forum. 2015 Nov 24;18(6):E226-31. doi: 10.1532/hsf.1469.

PMID:
26726709
13.

Two-Year Outcomes of Surgical Treatment of Severe Ischemic Mitral Regurgitation.

Goldstein D, Moskowitz AJ, Gelijns AC, Ailawadi G, Parides MK, Perrault LP, Hung JW, Voisine P, Dagenais F, Gillinov AM, Thourani V, Argenziano M, Gammie JS, Mack M, Demers P, Atluri P, Rose EA, O'Sullivan K, Williams DL, Bagiella E, Michler RE, Weisel RD, Miller MA, Geller NL, Taddei-Peters WC, Smith PK, Moquete E, Overbey JR, Kron IL, O'Gara PT, Acker MA; CTSN..

N Engl J Med. 2016 Jan 28;374(4):344-53. doi: 10.1056/NEJMoa1512913.

14.

Minimally invasive mitral valve repair through a right minithoracotomy approach.

Sorabella RA, Argenziano M.

Ann Cardiothorac Surg. 2015 Sep;4(5):478-9. doi: 10.3978/j.issn.2225-319X.2014.12.03. Review. No abstract available.

15.

Risk factors of infected sternal wounds versus sterile wound dehiscence.

Fu RH, Weinstein AL, Chang MM, Argenziano M, Ascherman JA, Rohde CH.

J Surg Res. 2016 Jan;200(1):400-7. doi: 10.1016/j.jss.2015.07.045.

PMID:
26371410
16.

Dextran-shelled oxygen-loaded nanodroplets reestablish a normoxia-like pro-angiogenic phenotype and behavior in hypoxic human dermal microvascular endothelium.

Basilico N, Magnetto C, D'Alessandro S, Panariti A, Rivolta I, Genova T, Khadjavi A, Gulino GR, Argenziano M, Soster M, Cavalli R, Giribaldi G, Guiot C, Prato M.

Toxicol Appl Pharmacol. 2015 Nov 1;288(3):330-8. doi: 10.1016/j.taap.2015.08.005.

PMID:
26276311
17.

Short-term outcomes in adult cardiac surgery in the use of del Nido cardioplegia solution.

Ota T, Yerebakan H, Neely RC, Mongero L, George I, Takayama H, Williams MR, Naka Y, Argenziano M, Bacha E, Smith CR, Stewart AS.

Perfusion. 2016 Jan;31(1):27-33. doi: 10.1177/0267659115599453.

PMID:
26228274
18.

Surgical Ablation for Atrial Fibrillation.

Gillinov M, Moskowitz AJ, Argenziano M.

N Engl J Med. 2015 Jul 30;373(5):484. doi: 10.1056/NEJMc1506893. No abstract available.

19.

Clinical Trial Design Principles and Endpoint Definitions for Transcatheter Mitral Valve Repair and Replacement: Part 2: Endpoint Definitions: A Consensus Document From the Mitral Valve Academic Research Consortium.

Stone GW, Adams DH, Abraham WT, Kappetein AP, Généreux P, Vranckx P, Mehran R, Kuck KH, Leon MB, Piazza N, Head SJ, Filippatos G, Vahanian AS; Mitral Valve Academic Research Consortium (MVARC)..

J Am Coll Cardiol. 2015 Jul 21;66(3):308-21. doi: 10.1016/j.jacc.2015.05.049.

20.

Clinical Trial Design Principles and Endpoint Definitions for Transcatheter Mitral Valve Repair and Replacement: Part 1: Clinical Trial Design Principles: A Consensus Document From the Mitral Valve Academic Research Consortium.

Stone GW, Vahanian AS, Adams DH, Abraham WT, Borer JS, Bax JJ, Schofer J, Cutlip DE, Krucoff MW, Blackstone EH, Généreux P, Mack MJ, Siegel RJ, Grayburn PA, Enriquez-Sarano M, Lancellotti P, Filippatos G, Kappetein AP; Mitral Valve Academic Research Consortium (MVARC)..

J Am Coll Cardiol. 2015 Jul 21;66(3):278-307. doi: 10.1016/j.jacc.2015.05.046.

Items per page

Supplemental Content

Loading ...
Support Center